Primary gait ignition disorder: Report of three cases
dc.contributor.buuauthor | Taşkapılıoğlu, Özlem | |
dc.contributor.buuauthor | Karlı, Necdet | |
dc.contributor.buuauthor | Erer, Sevda Özbek | |
dc.contributor.buuauthor | Zarifoğlu, Mehmet | |
dc.contributor.buuauthor | Bakar, Mustafa | |
dc.contributor.buuauthor | Turan, Faruk | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Nöroloji Anabilim Dalı. | tr_TR |
dc.contributor.researcherid | AAK-6623-2020 | tr_TR |
dc.contributor.scopusid | 23037226400 | tr_TR |
dc.contributor.scopusid | 6506587942 | tr_TR |
dc.contributor.scopusid | 25635370800 | tr_TR |
dc.contributor.scopusid | 6603411305 | tr_TR |
dc.contributor.scopusid | 26643051200 | tr_TR |
dc.contributor.scopusid | 17636734100 | tr_TR |
dc.date.accessioned | 2022-03-01T10:15:55Z | |
dc.date.available | 2022-03-01T10:15:55Z | |
dc.date.issued | 2009-08 | |
dc.description.abstract | Gait ignition failure (GIF) classifications all had major limitations. Few years ago, a new and simpler classification was proposed by Liston. The aim of this paper is to discuss three GIF patients with respect to this new classification. All three patients presented with hesitation to start walking and turning and their neurological examination revealed start and turn hesitation without any other abnormality. We classified our patients according to Liston's classification as ignition apraxia, which enabled us to approach the patients in a practical way. This classification helps to understand the underlying pathologies and combines clinical characteristics and pathophysiology. We reported our experience with pergolide in the treatment of patients suffering from primary GIF and underline the fact that more research is needed on the treatment of this condition. | en_US |
dc.identifier.citation | Taşkapılıoğlu, Ö. vd. (2009). "Primary gait ignition disorder: Report of three cases". Neurological Sciences, 30(4), 333-337. | en_US |
dc.identifier.endpage | 337 | tr_TR |
dc.identifier.issn | 1590-1874 | |
dc.identifier.issue | 4 | tr_TR |
dc.identifier.pubmed | 19484184 | tr_TR |
dc.identifier.scopus | 2-s2.0-67650999132 | tr_TR |
dc.identifier.startpage | 333 | tr_TR |
dc.identifier.uri | https://doi.org/10.1007/s10072-009-0093-z | |
dc.identifier.uri | https://link.springer.com/article/10.1007/s10072-009-0093-z | |
dc.identifier.uri | http://hdl.handle.net/11452/24769 | |
dc.identifier.volume | 30 | tr_TR |
dc.identifier.wos | 000267827700011 | |
dc.indexed.pubmed | Pubmed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.journal | Neurological Sciences | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Classification | en_US |
dc.subject | Imaging | en_US |
dc.subject | Primary gait ignition disorder | en_US |
dc.subject | Failure | en_US |
dc.subject | Parkinsonism | en_US |
dc.subject | Neurosciences & neurology | en_US |
dc.subject.emtree | Antiparkinson agent | en_US |
dc.subject.emtree | Benserazide plus levodopa | en_US |
dc.subject.emtree | Biperiden | en_US |
dc.subject.emtree | Entakapon | en_US |
dc.subject.emtree | Fosinopril | en_US |
dc.subject.emtree | Levodopa | en_US |
dc.subject.emtree | Pergolide | en_US |
dc.subject.emtree | Unclassified drug | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Apraxia | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Brain atrophy | en_US |
dc.subject.emtree | Brain ischemia | en_US |
dc.subject.emtree | Brain perfusion | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Clinical feature | en_US |
dc.subject.emtree | Differential diagnosis | en_US |
dc.subject.emtree | Disease classification | en_US |
dc.subject.emtree | Disease course | en_US |
dc.subject.emtree | Drug dose increase | en_US |
dc.subject.emtree | Drug response | en_US |
dc.subject.emtree | Drug treatment failure | en_US |
dc.subject.emtree | Drug withdrawal | en_US |
dc.subject.emtree | Follow up | en_US |
dc.subject.emtree | Frontal lobe | en_US |
dc.subject.emtree | Gait disorder | en_US |
dc.subject.emtree | Gait ignition disorder | en_US |
dc.subject.emtree | Gliosis | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Hyperactivity | en_US |
dc.subject.emtree | Lateral brain ventricle | en_US |
dc.subject.emtree | Limb movement | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Neurologic examination | en_US |
dc.subject.emtree | Nuclear magnetic resonance imaging | en_US |
dc.subject.emtree | Outpatient care | en_US |
dc.subject.emtree | Parkinson disease | en_US |
dc.subject.emtree | Pathophysiology | en_US |
dc.subject.emtree | Single photon emission computer tomography | en_US |
dc.subject.emtree | Tendon reflex | en_US |
dc.subject.emtree | Walking difficulty | en_US |
dc.subject.emtree | White matter | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Angiotensin-converting enzyme inhibitors | en_US |
dc.subject.mesh | Antiparkinson agents | en_US |
dc.subject.mesh | Atrophy | en_US |
dc.subject.mesh | Brain | en_US |
dc.subject.mesh | Fosinopril | en_US |
dc.subject.mesh | Gait apraxia | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Magnetic resonance imaging | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Neurologic examination | en_US |
dc.subject.mesh | Neuroprotective agents | en_US |
dc.subject.mesh | Neuropsychological tests | en_US |
dc.subject.mesh | Pergolide | en_US |
dc.subject.scopus | Electromyography; Brain Depth Stimulation; Movement Disorders | en_US |
dc.subject.wos | Clinical neurology | en_US |
dc.subject.wos | Neurosciences | en_US |
dc.title | Primary gait ignition disorder: Report of three cases | en_US |
dc.type | Article | |
dc.wos.quartile | Q4 | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: